Phreesia Inc (PHR) Stock Forecast & Price Target

Phreesia Inc has demonstrated a positive financial trajectory, with total revenue per Accountable Healthcare Services Client (AHSC) increasing by 5.6% year-over-year to $26,622, attributed to expansion across its various solution areas. The company reported a significant growth in patient payment volumes, reaching $1.181 billion in the third quarter of FY26, representing a 9.3% year-over-year increase, alongside an improved adjusted EBITDA guidance now projected between $99 million and $101 million, reflecting a robust 172% growth at the midpoint. Furthermore, management anticipates an end-of-year total of approximately 4,515 AHSCs for FY26, an increase from previous expectations, along with a continued rise in total revenue per AHSC compared to FY25.

Phreesia Inc. has reported a decline in its key metrics, indicating potential challenges ahead for the company’s financial performance. Specifically, management has revised its organic growth guidance for FY26 to approximately 13%, a decrease from the previous 18% in FY25, alongside a reduction in subscription revenue per client for FY27 to $51.8K, marking a 7% decline. Additionally, the company fell slightly short of client acquisition expectations and may face further risks to revenue if COVID-19 cases surge again, potentially impacting patient visit volumes.